084110.KQ
Huons Global Co., Ltd.
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 23,650.00
−3.47%Year over year
Reported trailing growth
- Revenue
- +4.1%
- EBITDA
- -63.4%
- EBIT
- -25.5%
- EPS
- +38.8%
- Free cash flow
- +224.3%
- Operating cash flow
- +6.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +8.5%
- EBITDA
- +42.6%
- EBIT
- +1.6%
- Net income
- -13.3%
- EPS
- -13.1%
- Free cash flow
- +59.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026